Lawsuit questions how accurately Oura Ring can identify sleep stages, putting the spotlight on the limits of consumer wearable health technology.
Oura, a wearable health technology brand, is facing a proposed class-action lawsuit in the United States over claims about the accuracy of its sleep-tracking technology. The complaint, filed in the US District Court for the Northern District of California, alleges that Oura misled consumers by presenting its smart rings as capable of accurately determining how much time users spend awake or in different stages of sleep, including light, deep, and REM sleep.
Madison Surber filed the lawsuit, alleging she purchased an Oura Ring after seeing the company’s marketing claims about its sleep-tracking capabilities. The allegations haven’t been established in court, and the case remains a proposed class action.
Questions about sleep-stage measurement.
At the centre of the dispute is a broader question about how consumer wearables measure sleep. According to the complaint, an Oura Ring cannot directly measure brain activity, which is traditionally used in clinical sleep assessments to determine sleep stages. Instead, wearable devices collect signals such as heart rate and other physiological measurements and use algorithms to estimate sleep patterns.
The lawsuit challenges whether those estimates can support the level of accuracy allegedly communicated in Oura’s marketing. This distinction matters as smart rings and other wearable devices increasingly position themselves as health-monitoring tools rather than simply tracking daily activity.
A growing debate around wearable health data.
The case arrives as Oura continues to expand beyond basic sleep monitoring. Its newer products and software have added features covering areas such as cardiovascular and respiratory health, activity, stress and women’s health.
The lawsuit therefore raises questions that extend beyond one company. As wearable technology becomes more sophisticated, consumers may increasingly rely on numerical scores and algorithm-generated insights to understand their health. The allegations against Oura will now move through the legal process, where the claims and supporting evidence can be examined. A lawsuit itself does not establish that the company’s technology or advertising violated the law.
For the wider wearable technology industry, however, the case highlights an increasingly important issue: how clearly companies distinguish between directly measured health data and algorithmic estimates, particularly when those metrics relate to sleep and other aspects of personal health.
